Study reveals mixed results for common stimulant in treating binge eating disorder

[Excerpt] Lisdexamfetamine, marketed as Vyvanse, first received approval from the Food and Drug Administration for the treatment of ADHD, “but its ability to also reduce the frequency of binge eating episodes led to its approval for binge eating disorder,” said Morgan James, assistant professor of psychiatry, member of the Rutgers Addiction Research Center at the…

Read More

Optimizing ADHD treatment: Revealing key components of cognitive–behavioral therapy

[Excerpt] While CBT can provide long-term tools for coping with the challenges of ADHD, it is a complex intervention with many different components. Could some components in CBT be consistently more effective than others? To answer this question, a research team from Japan conducted an extensive review and meta-analysis of existing literature on the subject.

Read More

Stimulant medications lower depression risk in children with ADHD

A meta-analysis of studies on children and adolescents with ADHD found that they are at an increased risk of depression and anxiety disorders. However, taking stimulant medication for ADHD was associated with a reduced risk of depression. The paper was published in the Journal of Psychiatric Research.

Read More

ADHD’s Sobering Life-Expectancy Numbers

When I was unexpectedly diagnosed with ADHD last year, it turned my entire identity upside down. At 37, I’d tamed my restlessness and fiery temper, my obsessive reorganization of my mental to-do list, and my tendency to write and rewrite the same sentence for hours. Being this way was exhausting, but that was just who…

Read More